These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38609799)

  • 1. Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer.
    Tini G; Tanda S; Toma M; Battistoni A; Musumeci B; Barbato E; Canepa M; Ameri P
    Heart Lung Circ; 2024 May; 33(5):704-709. PubMed ID: 38609799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry.
    Tomasoni D; Pagnesi M; Colombo G; Chiarito M; Stolfo D; Baldetti L; Lombardi CM; Adamo M; Maggi G; Inciardi RM; Loiacono F; Maccallini M; Villaschi A; Gasparini G; Montella M; Contessi S; Cocianni D; Perotto M; Barone G; Merlo M; Cappelletti AM; Rosano G; Sinagra G; Pini D; Savarese G; Metra M
    Eur J Heart Fail; 2024 Feb; 26(2):327-337. PubMed ID: 37933210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice.
    Savarese G; Lindberg F; Christodorescu RM; Ferrini M; Kumler T; Toutoutzas K; Dattilo G; Bayes-Genis A; Moura B; Amir O; Petrie MC; Seferovic P; Chioncel O; Metra M; Coats AJS; Rosano GMC
    Eur J Heart Fail; 2024 Jun; 26(6):1408-1418. PubMed ID: 38515385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community.
    Dunlay SM; Killian JM; Roger VL; Schulte PJ; Blecker SB; Savitz ST; Redfield MM
    J Card Fail; 2022 Oct; 28(10):1500-1508. PubMed ID: 35902033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
    Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS
    Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
    JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial.
    Cox ZL; Zalawadiya SK; Simonato M; Redfors B; Zhou Z; Kotinkaduwa L; Zile MR; Udelson JE; Lim DS; Grayburn PA; Mack MJ; Abraham WT; Stone GW; Lindenfeld J
    JACC Heart Fail; 2023 Jul; 11(7):791-805. PubMed ID: 37115135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Pharmacist-Led Heart Failure Clinic on Optimization of Guideline-Directed Medical Therapy (PHARM-HF).
    Patil T; Ali S; Kaur A; Akridge M; Eppes D; Paarlberg J; Parashar A; Jarmukli N
    J Cardiovasc Transl Res; 2022 Dec; 15(6):1424-1435. PubMed ID: 35501544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
    Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM
    J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta-analysis.
    Danielson C; Lileikyte G; Ouwerkerk W; S P Lam C; Erlinge D; Teng TK
    ESC Heart Fail; 2022 Aug; 9(4):2753-2761. PubMed ID: 35603531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure.
    Grewal D; Partow-Navid R; Garcia D; Coney J; Fraser G; Stoletniy L; Sakr A; Parwani P; Abramov D
    Am J Cardiol; 2021 Jul; 151():64-69. PubMed ID: 34167690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.
    Malgie J; Wilde MI; Clephas PRD; Emans ME; Koudstaal S; Schaap J; Mosterd A; van Ramshorst J; Wardeh AJ; van Wijk S; van den Heuvel M; Wierda E; Borleffs CJW; Saraber C; Beeres SLMA; van Kimmenade R; Jansen Klomp W; Denham R; da Fonseca CA; Klip IT; Manintveld OC; van der Boon RMA; van Ofwegen CEE; Yilmaz A; Pisters R; Linssen GCM; Faber N; van Heerebeek L; van de Swaluw JEC; Bouhuijzen LJ; Post MC; Kuijper AFM; Wu KW; van Beek EA; Hesselink T; Kleijn L; Kurvers MJM; Tio RA; Langerveld J; van Dalen BM; van Eck JWM; Handoko ML; Hermans WRM; Koornstra-Wortel HJJ; Szymanski MK; Rooker D; Tandjung K; Eijsbouts SCM; Asselbergs FW; van der Meer P; Brunner-La Rocca HP; de Boer RA; Brugts JJ
    Eur J Heart Fail; 2024 Jul; 26(7):1549-1560. PubMed ID: 38734980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.
    Kocabaş U; Ergin I; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir İ; Avcı Demir F; Doğduş M; Şen T; Altınsoy M; Üstündağ S; Urgun ÖD; Sinan ÜY; Uygur B; Yeni M; Özçalık E
    ESC Heart Fail; 2023 Dec; 10(6):3677-3689. PubMed ID: 37804042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy.
    Malgie J; Clephas PRD; Brunner-La Rocca HP; de Boer RA; Brugts JJ
    Heart Fail Rev; 2023 Sep; 28(5):1221-1234. PubMed ID: 37311917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.
    Samsky MD; Lin L; Greene SJ; Lippmann SJ; Peterson PN; Heidenreich PA; Laskey WK; Yancy CW; Greiner MA; Hardy NC; Kavati A; Park S; Mentz RJ; Fonarow GC; O'Brien EC
    JAMA Cardiol; 2020 Mar; 5(3):292-299. PubMed ID: 31734700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020.
    Ødegaard KM; Lirhus SS; Melberg HO; Hallén J; Halvorsen S
    ESC Heart Fail; 2023 Feb; 10(1):405-415. PubMed ID: 36266969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure medication dosage and survival in women and men seen at outpatient clinics.
    Bots SH; Onland-Moret NC; Tulevski II; van der Harst P; Cramer MJM; Asselbergs FW; Somsen GA; den Ruijter HM
    Heart; 2021 Nov; 107(21):1748-1755. PubMed ID: 34261736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study.
    Quiroga B; Ortiz A; Núñez S; Kislikova M; González Sanchidrián S; Broseta JJ; Albines ZS; Escamilla Cabrera B; Rivero Viera Y; Rodriguez Santarelli D; Salanova Villanueva L; Lopez Rodriguez F; Cancho Castellano B; Ibáñez Cerezon M; Gutierrez Rivas CP; Aresté N; Campos Gutiérrez B; Ródenas Gálvez A; Glucksmann Pizá MC; Balda Manzanos S; Soldevila A; Rodríguez Gayo L; Moral Berrio E; Ortega Diaz M; Beltrán Catalán S; Puente García A; Ángel Rojas M; Sosa Barrios RH; Santana Zapatero H; Rangel Hidalgo G; Martinez Canet AM; Díez J;
    Cardiorenal Med; 2024; 14(1):202-214. PubMed ID: 38513622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.